{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-003756","form_type":"8-K","ticker":"BFRI","cik":"0001858685","company_name":"Biofrontera Inc.","filed_at":"2024-01-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:26.107513+00:00","generated_at":"2026-06-06T18:31:54.809746+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Biofrontera gets Nasdaq extension until May 20, 2024 to regain compliance","bullets":["Nasdaq granted a 180-day extension from Nov 22, 2023 (new deadline May 20, 2024) to regain compliance.","Company had submitted a compliance plan on January 8, 2024, after initial delisting notice.","Must demonstrate compliance with Nasdaq continued listing requirements by the extended deadline."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-003756","json":"https://secwatch.observer/filing/0001493152-24-003756.json","markdown":"https://secwatch.observer/filing/0001493152-24-003756.md","text":"https://secwatch.observer/filing/0001493152-24-003756.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1858685/000149315224003756/0001493152-24-003756-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1858685/000149315224003756/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T18:31:54.809746+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}